Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34)

The summary for the Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34): -Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www2.niddk.nih.gov) on behalf of the NIH Genes, Environment and Health Initiative solicits Implementation Planning Grant (U34) applications from institutions/ organizations that propose to plan for multicenter research on a) educational and communication initiatives for health care providers and consumers regarding interpretation of and findings from genetic studies of common diseases and the results of their dissemination and b) behavioral or psychosocial aspects of clinical application of genetic findings. Areas of interest include, but are not limited to: research on patient or provider education regarding genetic findings or clinical outcomes of genetic testing; research on patient or provider perceptions of environmental or other risk factors that may have specific interactions with gene variants; and assessments of responses to use of personal genetic information in clinical care and disease prevention. The proposed research must focus on using findings from genetic studies of common diseases with complex genetic etiology in clinical settings. This FOA will support planning and preliminary or feasibility studies for investigator-initiated, multi-center clinical studies through an implementation planning (U34) grant. The U34 planning grant is designed to: (1) permit early peer review of the rationale for the proposed clinical study; (2) permit assessment of the design/protocol of the proposed study; (3) provide support for the development of a complete study protocol and associated documents including a manual of operations, (4) support the development of other essential elements required for the conduct of a clinical study, and (5) carry out key preliminary or feasibility studies. Completion of the required products of a U34 grant is a prerequisite for submission of a multi-center clinical study cooperative agreement (U01) application, which will support the actual conduct of the study. -Mechanism of Support. This FOA will utilize the U34 grant mechanism and runs in parallel with an FOA, RFA-DK-08-004, that solicits applications under the R21 mechanism.